Impact of melatonin on immunity: A review

Central European Journal of Medicine

Volumn 8, Issue 4, 2013, Pages 369-376

  Pohanka, Miroslav ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Antioxidant; Autoimmunity; Inflammation; Lymphocyte; Macrophage; Melatonin; Neuroinflammation; Sleep

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN 3 RECEPTOR; MELATONIN RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CELL CYCLE REGULATION; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DISEASE CONTROL; ENZYME INHIBITION; ENZYME REGULATION; EPILEPSY; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NONREM SLEEP; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SLEEP QUALITY; UPREGULATION; VIRUS INFECTION;

EID: 84879212642     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-013-0177-2     Document Type: Review

References (75)

1. Ivanova TN, Iuvone PM. Melatonin synthesis in retina: circadian regulation of arylalkylamine N-acetyltransferase activity in cultured photoreceptor cells of embryonic chicken retina. Brain Res 2003; 973: 56-63
2. do Carmo Buonfiglio D, Peliciari-Garcia RA, do Amaral FG et al. Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats. Invest Ophthalml Vis Sci 2011; 52: 7416-7422
3. Konturek PC, Brzozowski T, Konturek SJ. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol 2011; 62: 139-150
4. Hasan S, Santhi N, Lazar AS et al. Assessment of circadian rhythms in humans: comparison of realtime fibroblast reporter imaging with plasma melatonin. Faseb J 2012; 26: 2414-2423 DOI: 10.1096/fj.11-201699
5. Smulevich AB, Dubnitskaya EB. A dimensional rhythmological model of depression. Z Nevrol Psikhiatrii Im S S Korsakova 2010; 110: 4-10
6. Hur SP, Takeuchi Y, Itoh H et al. Fish sleeping under sandy bottom: Interplay of melatonin and clock genes. Gen Comp Endocrinol 2012; 177: 37-45 DOI: 10.1016/j.ygcen.2012.01.007
7. Barrett P, Bolborea M. Molecular pathways involved in seasonal body weight and reproductive responses governed by melatonin. J Pineal Res 2012; 52: 376-388 DOI: 10.1111/j.1600-079X.2011.00963.x
8. Deregnaucourt S, Saar S, Gahr M. Melatonin affects the temporal pattern of vocal signatures in birds. J Pineal Res 2012; 53: 245-258 DOI: 10.1111/j.1600-079X.2012.00993.x
9. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60: 97-108 DOI: 10.1016/j.biopha.2006.01.002
10. Jaworek J, Szklarczyk J, Jaworek AK et al. Protective effect of melatonin on acute pancreatitis. Int J Inflam 2012; 2012: 173675
11. Pohanka M. Alzheimer's disease and related neurodegenerative disorders: implication and counteracting of melatonin. Journal of Applied Biomedicine 2011; 9: 185-196 DOI: DOI 10.2478/v10136-011-0003-6
12. Alonso-Vale MI, Andreotti S, Mukai PY et al. Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res 2008; 45: 422-429
13. Gumenyuk V, Roth T, Drake CL. Circadian phase, sleepiness, and light exposure assessment in night workers with and without shift work disorder. Chronobiol Int 2012; 29: 928-936
14. Bhatti P, Mirick DK, Davis S. Invited commentary: shift work and cancer. Am J Epidemiol 2012; 176: 760-763
15. Rodriguez-Naranjo MI, Moya ML, Cantos-Villar E et al. Comparative evaluation of the antioxidant activity of melatonin and related indoles. J Food Compos Anal 2012; 28: 16-22 DOI: 10.1016/j.jfca.2012.07.001
16. Ozturk G, Akbulut KG, Guney S et al. Age-related changes in the rat brain mitochondrial antioxidative enzyme ratios: Modulation by melatonin. Exp Gerontol 2012; 47: 706-711 DOI: 10.1016/j.exger.2012.06.011
17. Ozturk G, Coskun S, Erbas D et al. The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol 2000; 50: 149-153 DOI: 10.2170/jjphysiol.50.149
18. Cutando A, Aneiros-Fernandez J, Lopez-Valverde A et al. A new perspective in Oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR/ROR in the oral cavity. Arch Oral Biol 2011; 56: 944-950
19. Dubocovich ML. Melatonin receptors: Role on sleep and circadian rhythm regulation. Sleep Med 2007; 8: S34-S42 DOI: 10.1016/j.sleep.2007.10.007
20. Mor M, Rivara S, Pala D et al. Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. Expert Opin Ther Pat 2010; 20: 1059-1077
21. Spadoni G, Bedini A, Rivara S et al. Melatonin receptor agonists: new options for insomnia and depression treatment. CNS Neurosci Ther 2011; 17: 733-741
22. Vella F, Gilles FA, Delagrange P et al. NRH: quinone reductase 2: An enzyme of surprises and mysteries. Biochem Pharmacol 2005; 71: 1-12 DOI: 10.1016/j.bcp.2005.09.019
23. Tan DX, Manchester LC, Terron MP et al. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance. J Pineal Res 2007; 43: 317-320 DOI: 10.1111/j.1600-079X.2007.00513.x
24. Boutin JA, Marcheteau E, Henning P et al. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate. J Pineal Res 2008; 45: 524-531
25. Boutin JA, Saunier C, Guenin SP et al. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis. Arch Biochem Biophys 2008; 477: 12-19 DOI: 10.1016/j. abb.2008.04.040
26. Reybier K, Perio P, Ferry G et al. Insights into the redox cycle of human quinone reductase 2. Free Radic Res 2011; 45: 1184-1195 DOI: 10.3109/10715762.2011.605788
27. Carbajo-Pescador S, Martin-Renedo J, Garcia-Palomo A et al. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells. J Pineal Res 2009; 47: 330-338 DOI: 10.1111/j.1600-079X.2009.00719.x
28. Stehlin-Gaon C, Willmann D, Zeyer D et al. Alltrans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol 2003; 10: 820-825 DOI: 10.1038/nsb979
29. Lardone PJ, Guerrero JM, Fernandez-Santos JM et al. Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor. J Pineal Res 2011; 51: 454-462 DOI: 10.1111/j.1600-079X.2011.00909.x
30. Missbach M, Jagher B, Sigg I et al. Thiazolidine diones, specific ligands of the nuclear receptor retinoid Z receptor/retinoid acid receptor-related orphan receptor alpha with potent antiarthritic activity. Journal of Biological Chemistry 1996; 271: 13515-13522
31. Agez L, Laurent V, Pevet P et al. Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience 2007; 144: 522-530 DOI: 10.1016/j.neuroscience.2006.09.030
32. Kiefer TL, Lai L, Yuan L et al. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res 2005; 38: 231-239 DOI: 10.1111/j.1600-079X.2004.00198.x
33. Pohanka M. Antioxidants countermeasures against sulfur mustard. Mini-Rev Med Chem 2012; 12: 742-748
34. Tamura EK, Cecon E, Monteiro AWA et al. Melatonin inhibits LPS-induced NO production in rat endothelial cells. J Pineal Res 2009; 46: 268-274 DOI: 10.1111/j.1600-079X.2008.00657.x
35. Camacho ME, Carrion MD, Lopez-Cara LC et al. Melatonin synthetic analogs as nitric oxide synthase inhibitors. Mini-Rev Med Chem 2012; 12: 600-617
36. Koh PO. Melatonin regulates nitric oxide synthase expression in ischemic brain injury. J Vet Med Sci 2008; 70: 747-750 DOI: 10.1292/jvms.70.747
37. Marczynski TJ, Yamaguchi N, Ling GM et al. Sleep induced by the administration of melatonin (5-methoxynacetyltryptamine) to the hypothalamus in unrestrained cats. Experimentia 1964; 20: 435-437
38. Pieri C, Marra M, Moroni F et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sciences 1994; 55: 271-276
39. Pieri C, Moroni F, Marra M et al. Melatonin is an efficient antioxidant. Arch Gerontol Geriatr 1995; 20: 159-165
40. Chen HY, Chen TY, Lee MY et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 2006; 41: 175-182
41. Shirazi A, Ghobadi G, Ghazi-Khansari M. A radiobiological review on melatonin: a novel radioprotector. J Radiat Res 2007; 48: 263-272
42. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42
43. Fischer TW, Kleszczynski K, Hardkop LH et al. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVRinduced depletion, and protects against the formation of DNA damage (8-hydroxy-2′- deoxyguanosine) in ex vivo human skin. J Pineal Res 2012; doi: 10.1111/jpi.12018
44. Shagirtha K, Muthumani M, Prabu SM. Melatonin abrogates cadmium induced oxidative stress related neurotoxicity in rats. Eur Rev Med Pharmacol Sci 2011; 15: 1039-1050
45. Korkmaz GG, Uzun H, Cakatay U et al. Melatonin ameliorates oxidative damage in hyperglycemiainduced liver injury. Clinical and investigative medicine Medecine clinique et experimentale 2012; 35: E370
46. Ali SA, Aly HF, Faddah LM et al. Dietary supplementation of some antioxidants against hypoxia. World J Gastroenterol 2012; 18: 6379-6386
47. Karaoz E, Gultekin F, Akdogan M et al. Protective role of melatonin and a combination of vitamin C and vitamin E on lung toxicity induced by chlorpyrifosethyl in rats. Exp Toxicol Pathol 2002; 54: 97-108
48. Yellon SM, Tran LT. Photoperiod, reproduction, and immunity in select strains of inbred mice. J Biol Rhythms 2002; 17: 65-75
49. Zhang Z, Inserra PF, Liang B et al. Melatonin, immune modulation and aging. Autoimmunity 1997; 26: 43-53
50. Santello FH, Frare EO, dos Santos CD et al. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi. J Pineal Res 2008; 45: 291-296
51. Brazao V, Del Vecchio Filipin M, Santello FH et al. Melatonin and zinc treatment: distinctive modulation of cytokine production in chronic experimental Trypanosoma cruzi infection. Cytokine 2011; 56: 627-632
52. Xia MZ, Liang YL, Wang H et al. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. J Pineal Res 2012; 53: 325-334
53. Lee YD, Kim JY, Lee KH et al. Melatonin attenuates lipopolysaccharide- induced acute lung inflammation in sleep-deprived mice. J Pineal Res 2009; 46: 53-57
54. Sinanoglu O, Sezgin G, Ozturk G et al. Melatonin with 1,25-Dihydroxyvitamin D3 Protects against Apoptotic Ischemia-Reperfusion Injury in the Rat Kidney. Ren Fail 2012; 34: 1021-1026 DOI: 10.3109/0886022x.2012. 700887
55. Cotto-Rios XM, Bekes M, Chapman J et al. Cell Rep. Deubiquitinases as a Signaling Target of Oxidative Stress 2012; doi: 10.1016/j.celrep.2012.11.011
56. Kodama R, Kato M, Furuta S et al. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. Genes Cells 2012; doi: 10.1111/gtc.12015
57. Liu RM, Choi J, Wu JH et al. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem 2010; 285: 16239-16247
58. Cutando A, Lopez-Valverde A, Arias-Santiago S et al. Role of melatonin in cancer treatment. Anticancer Res 2012; 32: 2747-2753
59. Brigo F, Del Felice A. Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev 2012; 6: CD006967
60. Boga JA, Coto-Montes A, Rosales-Corral SA et al. Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"? Rev Med Virol 2012; 22: 323-338 DOI: 10.1002/rmv.1714
61. Pohanka M. Acetylcholinesterase inhibitors: a patent review (2008 - present). Expert Opin Ther Pat 2012; 22: 871-886 DOI: 10.1517/13543776.2012. 701620
62. Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2011; 155: 219-229 DOI: 10.5507/bp.2011.036
63. Martino M, Rocchi G, Escelsior A et al. Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance. Curr Neuropharmacol 2012; 10: 97-123
64. Islam MA, Uddin MJ, Tholen E et al. Age-related changes in phagocytic activity and production of pro-inflammatory cytokines by lipopolysaccharide stimulated porcine alveolar macrophages. Cytokine 2012; 60: 707-717 DOI: 10.1016/j.cyto.2012.08.011
65. van Besouw NM, Verjans G, Zuijderwijk JM et al. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients. J Med Virol 2012; 84: 2018-2025 DOI: 10.1002/jmv.23427
66. Rybka J, Kedziora-Kornatowska K, Kedziora J et al. Immunosenescence and late life depression. Centr Eur J Immunol 2009; 34: 271-275
67. Manikonda PK, Jagota A. Melatonin administration differentially affects age-induced alterations in daily rhythms of lipid peroxidation and antioxidant enzymes in male rat liver. Biogerontology 2012; 13: 511-524 DOI: 10.1007/s10522-012-9396-1
68. Rastmanesh R. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity. Med Hypotheses 2011; 76: 79-85 DOI: 10.1016/j.mehy.2010.08.036
69. Mozaffari S, Abdollahi M. Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences. Curr Pharm Design 2011; 17: 4372-4378
70. Huai JP, Sun XC, Chen MJ et al. Melatonin attenuates acute pancreatitis-associated lung injury in rats by modulating interleukin 22. World Journal of Gastroenterology 2012; 18: 5122-5128 DOI: 10.3748/wjg.v18.i36.5122
71. Srinivasan V, Spence DW, Trakht I et al. Immunomodulation by melatonin: Its significance for seasonally occurring diseases. Neuroimmunomodulation 2008; 15: 93-101 DOI: 10.1159/000148191
72. Lissoni P. Is there a role for melatonin in supportive care? Support Care Cancer 2002; 10: 110-116 DOI: 10.1007/s005200100281
73. Bekyarova G, Bratchkova Y, Tancheva S et al. Effective melatonin protection of burn-induced hepatic disorders in rats. Cent Eur J Med 2012; 7: 533-538 DOI: 10.2478/s11536-012-0006-z
74. Bekyarova G, Apostolova M, Kotzev I. Melatonin protection against burn-induced hepatic injury by down-regulation of nuclear factor kappa B activation Int J Immunopathol Pharmacol 2012; 25: 591-596
75. Terry PD, Villinger F, Bubenik GA et al. Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research. Inflamm Bowel Dis 2009; 15: 134-140 DOI: 10.1002/ibd.20527